Showing results (1611-1620 of 1,655) with videos related to

Sort By:
Pageof 166
Neuro-Oncology|November 4, 2024
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect groupPhilipp Karschnia, Jacob S Young, Gilbert C Youssef, et al.
Acta Neuropathologica|December 11, 2023
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockadeSara Hadad, Rohit Gupta, Nancy Ann Oberheim Bush, et al.
Journal of Neurosurgery. Spine|October 2, 2020
Consensus-based perioperative protocols during the COVID-19 pandemicPraveen V Mummaneni, John F Burke, Andrew K Chan, et al.
Cell|November 19, 2016
Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive GrowthBaoli Hu, Qianghu Wang, Y Alan Wang, et al.
Nature Genetics|June 9, 2014
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma riskKyle M Walsh, Veryan Codd, Ivan V Smirnov, et al.
Neuro-Oncology Advances|August 22, 2025
Estimating overall survival of glioblastoma patients using clinical variables, tumor size, and locationAlexandros Ferles, Paulina Majewska, Ragnhild Holden Helland, et al.
Neuro-Oncology|January 31, 2013
Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histologyTerri Rice, Shichun Zheng, Paul A Decker, et al.
Neuro-Oncology|October 14, 2022
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directionsJulie J Miller, L Nicolas Gonzalez Castro, Samuel McBrayer, et al.
Journal of Neurosurgery|January 17, 2025
Prognostic value of manual versus automatic methods for assessing extents of resection and residual tumor volume in glioblastomaPaulina Majewska, Ragnhild Holden Helland, Alexandros Ferles, et al.
Neuro-Oncology|November 19, 2024
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responsesCalixto-Hope G Lucas, Nadeem N Al-Adli, Jacob S Young, et al.
Pageof 166